1. Japan Stocks

  2. •

    Consumer Defensive

  3. •

    Beverages - Non-Alcoholic
Yakult Honsha Co.,Ltd.

Yakult Honsha Co.,Ltd.

YKLTF
Yakult Honsha Co.,Ltd.US flagOther OTC
15.85
USD
- -
- -
4.56BMarket Cap
Yakult Honsha Co.,Ltd.
YKLTF
(Other OTC)

Recent

price

15.85

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
FRC
889.29
909.09
925.92
1,044.57
1,113.05
1,181.28
1,144.12
1,220.2
1,269.29
1,267.19
1,202.53
1,295.49
1,546.18
1,622.68
1,651,326.03
1,657.64
825.58
Revenue per Share
38.28
38.66
47.51
67.22
75.79
87.27
91.2
103.51
108.95
124.02
122.42
140.18
162.09
164.52
150,475.06
150.72
82.25
Basic EPS, GAAP
119.14
97.28
124.41
144.85
167.59
188.05
181.45
188.36
193.74
195.98
174.03
229.03
276.91
228.05
279,869.13
177.62
- -
Free Cash Flow per Basic Share
9.98
11.47
11.23
11.8
12.23
18.7
20.46
16.56
18.47
23.47
24.46
31
40.69
50.28
60,136.49
65.45
- -
Dividend per Share
674.69
702.88
737.26
813.22
904.98
973.8
1,044.05
1,062.59
1,181.48
1,282.99
1,379.52
1,490.01
1,649.53
1,776.47
1,910,477.7
1,726.76
1,879.59
Book Value per Share
712.32
716.5
814.53
900.32
1,075.99
1,089.5
1,123.28
1,157.54
1,208.42
1,272.27
1,354.28
1,496.57
1,728.15
1,933.29
2,046,398.65
2,194.67
2,153.07
Tangible Book Value per Share
344
344
345
335
331
330
331
329
321
320
321
320
312
310
- -
293
303
Basic Weighted Avg Shares
305,944
312,552
319,193
350,322
367,980
390,412
378,307
401,569
407,017
406,004
385,706
415,116
483,071
503,079
499,683
486,425
250,250
Sales/Revenue/Turnover
6.67
6.66
7.23
9.14
9.48
10.26
9.86
10.82
11.26
11.25
11.33
12.82
13.68
12.6
11.09
9.29
11.23
Operating Margin (%)
19,628
18,337
19,434
20,077
22,793
24,364
22,660
21,532
21,237
22,324
22,113
23,769
25,333
27,841
29,978
28,809
- -
Depreciation Expense
13,168
13,291
16,379
22,543
25,056
28,843
30,154
34,064
34,935
39,735
39,267
44,917
50,641
51,006
45,533
44,228
24,932
Net Income, GAAP
24.61
33.02
30.46
31.4
32.34
30.35
28.16
27.71
27.99
23.65
26.7
29.07
28.83
28.03
31.85
28.96
23.97
Effective Tax Rate (%)
4.3
4.25
5.13
6.43
6.81
7.39
7.97
8.48
8.58
9.79
10.18
10.82
10.48
10.14
9.11
9.09
9.96
Profit Margin (%)
119,655
105,613
63,915
102,354
110,238
110,016
114,643
83,481
132,182
156,744
173,254
211,117
206,550
226,594
220,078
191,916
250,892
Working Capital
49,946
47,796
6,173
74,278
74,834
69,757
62,855
46,512
80,056
77,675
72,005
67,046
22,396
38,543
32,658
58,300
26,952
LT Debt
250,971
252,241
287,098
308,032
362,211
365,462
376,880
386,672
392,278
412,081
439,761
484,935
545,494
605,945
629,513
654,320
660,251
Total Equity
4.88
4.43
4.75
5.57
5.16
5.73
5.47
6.15
6.3
6.62
5.95
6.76
7.8
6.79
5.19
4.19
2.99
Return on Invested Capital (%)
3.46
3
4.09
4.8
4.57
5.08
5.36
5.91
5.7
6.4
6.23
6.98
7.41
6.65
5.11
5.58
3.1
Return on Capital (%)
5.84
5.61
6.61
8.56
8.76
9.29
9.04
9.8
9.59
10.06
9.2
9.77
10.2
9.57
8.07
8.15
4.52
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Mar'24
Jun'25
Sep'25
ST Debt
57,985
- -
45,349
LT Borrowings
30,335
- -
26,952
LT Finance Leases
8,208
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
303
- -
303
Market Capitalization
1,181,339
890,524
897,551

Working Capital

FRC

•

in mil. unless spec.
Mar'24
Jun'25
Sep'25
Total Current Assets
372,161
- -
394,878
Cash, Cash Equivalents & STI
255,257
- -
274,265
Accounts Receivable, Net
61,218
- -
63,127
Inventories
37,088
- -
36,296
Total Current Liabilities
145,567
- -
143,986
Payables & Accruals
- -
- -
- -
ST Debt
57,985
- -
45,349
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
6.06%
8.33%
3.94%
Free Cash Flow
0.25%
2.48%
-38.45%
Net Income, GAAP
4.69%
2.85%
-2.87%
Sales/Revenue/Turnover
2.4%
4.96%
-2.65%
Total Cash Common Dividend
12.95%
19.9%
5.54%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
122,115
130,714
134,892
115,358
503,079
2025
- -
- -
- -
- -
499,683
2026
- -
- -
- -
- -
486,425

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
42
- -
- -
- -
164.52
2025
- -
- -
- -
- -
150,475.06
2026
- -
- -
- -
- -
150.72

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
50.28
2025
- -
- -
- -
- -
60,136.49
2026
- -
- -
- -
- -
65.45
Similar Companies
Lassonde Industries Inc. (LSDAF)
The Alkaline Water Company Inc. (WTERD)
Coca-Cola FEMSA, S.A.B. de C.V. (COCSF)
Coca-Cola FEMSA, S.A.B. de C.V. (KOFUBL.MX)
Haad Thip Public Company Limited (HTC-R.BK)
Suntory Beverage & Food Limited (2587.T)
Business
Yakult Honsha Co., Ltd. is a distinguished Japanese multinational corporation primarily focused on enhancing global well-being through its diverse product offerings. The company is best known for its signature probiotic fermented milk beverage, Yakult, which contains the unique *Lacticaseibacillus paracasei* Shirota strain, a result of pioneering research into beneficial lactic acid bacteria. Established in 1955, Yakult Honsha's operations are divided across several key segments: Food and Beverages in Japan, the Americas, Asia and Oceania, and Europe; Pharmaceuticals; and an "Others" category. Its food and beverage portfolio extends beyond its flagship drink to include various fermented milk products, juices, and noodles, distributed through both retail channels and a distinctive home delivery system utilizing "Yakult Ladies" globally. Beyond its prominent role in the food and beverage industry, Yakult Honsha maintains a significant presence in the pharmaceutical sector, with a particular emphasis on oncology treatments and other medicinal products. The company also develops and markets a range of cosmetics, leveraging its scientific expertise in fermentation and beneficial microbes for skincare applications, often incorporating its proprietary moisturizing agent, S.E. (Shirota Essence). Additionally, the "Others" segment notably includes the operation of the Tokyo Yakult Swallows, a professional baseball team competing in Nippon Professional Baseball's Central League. Headquartered in Tokyo, Japan, Yakult Honsha continues to expand its global footprint, driven by its foundational philosophy of promoting preventive medicine and gut health. The company reported revenues of ¥499.68 billion in the fiscal year ending March 2025. Recent strategic moves include updating material issues and establishing a European R&D Center in the Netherlands in September 2025, alongside ongoing equity buyback programs.